|
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months. |
2011-04-29 |
CIGB |
|
Alum Phospate Adjuvated QuimiHib® Vaccine Clinical Study. |
2011-04-28 |
CIGB |
|
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks. |
2011-04-27 |
CIGB |
|
h-R3 MAb combined with radio chemotherapy to treat non-surgical esophagus tumors of epithelial origin. |
2010-12-29 |
CIM |
|
Patients with non small cells lung cancer (NSCLC) and brain metastasis. |
2010-12-29 |
CIM |
|
14F7 MAb marked with Tc99 Phase II in breast tumors. |
2010-12-29 |
CIM |
|
Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patients |
2010-12-28 |
CIM |
|
Anti-idiotype 1E10 vaccine in the treatment of patients with small cell lung (SCLC) patients |
2010-12-28 |
CIM |
|
hR3 MaB and radiotherapy in highly malignant astrocytic tumors, phase III. |
2010-12-28 |
CIM |
|
InCarbacel-II |
2010-12-28 |
CIGB |
|
1E10 anti-idiotype vaccine, metastatic breast cancer, phase II |
2010-12-27 |
CIM |
|
Clinical trial, phase II: Evaluation of TheraCIM hR3 MaB combined with chemo- and radio-therapy to treat patients with epithelial tumors in neck of the uterus, stage III. |
2010-12-27 |
CIM |
|
Toxicological evaluation of the humanized Anti-CD6 MAb T1h in Rheumatoid Arthritis Patients |
2010-12-24 |
CIM |
|
Pharmacokinetics of intralesional EGF in patients with diabetic foot ulcers. |
2010-12-24 |
CIGB |
|
InCCNM -I |
2010-12-24 |
CIGB |
|
Application of CIGB-128 in keloid patients undergoing surgical exeresis. |
2010-12-24 |
CIGB |
|
CIGB500 in healthy volunteers |
2010-12-20 |
CIGB |
|
THERESA-2 Study |
2010-12-20 |
CIGB |
|
Dynamic-I |
2010-12-20 |
CIGB |
|
Advanced breast cancer treatment with hR3 monoclonal antibody combined with doxorubicin and cyclophosphamide, phase I. |
2010-12-17 |
CIM |
